Medical Care
Global Nuclear Medicine Market Research Report 2025
- Mar 11, 25
- ID: 56875
- Pages: 84
- Figures: 85
- Views: 8
The global market for Nuclear Medicine was valued at US$ 6875 million in the year 2024 and is projected to reach a revised size of US$ 11090 million by 2031, growing at a CAGR of 7.4% during the forecast period.
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Market Drivers
The nuclear medicine market is experiencing significant growth due to the increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, which require advanced diagnostic and therapeutic solutions. Nuclear medicine provides highly targeted treatment, such as radioisotope therapy, and is crucial for precise imaging techniques like PET and SPECT, which offer better disease detection and management. Advances in radiopharmaceuticals, such as the development of new radioisotopes, and the rising demand for personalized medicine further fuel the market's expansion. Additionally, the growing emphasis on early diagnosis and treatment monitoring in healthcare systems, along with the availability of funding for research and development in nuclear medicine, contributes to market growth.
Market Challenges
Despite its advantages, the nuclear medicine market faces challenges related to the high costs of nuclear medicine treatments and imaging technologies. The infrastructure required for nuclear medicine, including specialized facilities, trained professionals, and the availability of radiopharmaceuticals, can be prohibitively expensive, especially in developing regions. Additionally, concerns over the safe handling and disposal of radioactive materials, regulatory hurdles, and the relatively short half-life of certain isotopes create logistical difficulties in terms of production, distribution, and patient access. These challenges can limit the widespread adoption of nuclear medicine, particularly in low-resource healthcare settings.
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine.
The Nuclear Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Yantai Dongcheng
Segment by Type
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
Segment by Application
Oncology
Thyroid
Cardiology
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Market Drivers
The nuclear medicine market is experiencing significant growth due to the increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, which require advanced diagnostic and therapeutic solutions. Nuclear medicine provides highly targeted treatment, such as radioisotope therapy, and is crucial for precise imaging techniques like PET and SPECT, which offer better disease detection and management. Advances in radiopharmaceuticals, such as the development of new radioisotopes, and the rising demand for personalized medicine further fuel the market's expansion. Additionally, the growing emphasis on early diagnosis and treatment monitoring in healthcare systems, along with the availability of funding for research and development in nuclear medicine, contributes to market growth.
Market Challenges
Despite its advantages, the nuclear medicine market faces challenges related to the high costs of nuclear medicine treatments and imaging technologies. The infrastructure required for nuclear medicine, including specialized facilities, trained professionals, and the availability of radiopharmaceuticals, can be prohibitively expensive, especially in developing regions. Additionally, concerns over the safe handling and disposal of radioactive materials, regulatory hurdles, and the relatively short half-life of certain isotopes create logistical difficulties in terms of production, distribution, and patient access. These challenges can limit the widespread adoption of nuclear medicine, particularly in low-resource healthcare settings.
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine.
The Nuclear Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Yantai Dongcheng
Segment by Type
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
Segment by Application
Oncology
Thyroid
Cardiology
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnostic Nuclear Medicine
1.2.3 Therapeutic Nuclear Medicine
1.3 Market by Application
1.3.1 Global Nuclear Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Medicine Market Perspective (2020-2031)
2.2 Global Nuclear Medicine Growth Trends by Region
2.2.1 Global Nuclear Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nuclear Medicine Historic Market Size by Region (2020-2025)
2.2.3 Nuclear Medicine Forecasted Market Size by Region (2026-2031)
2.3 Nuclear Medicine Market Dynamics
2.3.1 Nuclear Medicine Industry Trends
2.3.2 Nuclear Medicine Market Drivers
2.3.3 Nuclear Medicine Market Challenges
2.3.4 Nuclear Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Medicine Players by Revenue
3.1.1 Global Top Nuclear Medicine Players by Revenue (2020-2025)
3.1.2 Global Nuclear Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Top Nuclear Medicine Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nuclear Medicine Revenue
3.4 Global Nuclear Medicine Market Concentration Ratio
3.4.1 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Revenue in 2024
3.5 Global Key Players of Nuclear Medicine Head office and Area Served
3.6 Global Key Players of Nuclear Medicine, Product and Application
3.7 Global Key Players of Nuclear Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclear Medicine Breakdown Data by Type
4.1 Global Nuclear Medicine Historic Market Size by Type (2020-2025)
4.2 Global Nuclear Medicine Forecasted Market Size by Type (2026-2031)
5 Nuclear Medicine Breakdown Data by Application
5.1 Global Nuclear Medicine Historic Market Size by Application (2020-2025)
5.2 Global Nuclear Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nuclear Medicine Market Size (2020-2031)
6.2 North America Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nuclear Medicine Market Size by Country (2020-2025)
6.4 North America Nuclear Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nuclear Medicine Market Size (2020-2031)
7.2 Europe Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nuclear Medicine Market Size by Country (2020-2025)
7.4 Europe Nuclear Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Medicine Market Size (2020-2031)
8.2 Asia-Pacific Nuclear Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nuclear Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Nuclear Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nuclear Medicine Market Size (2020-2031)
9.2 Latin America Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nuclear Medicine Market Size by Country (2020-2025)
9.4 Latin America Nuclear Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Medicine Market Size (2020-2031)
10.2 Middle East & Africa Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nuclear Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Nuclear Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cardinal Health
11.1.1 Cardinal Health Company Details
11.1.2 Cardinal Health Business Overview
11.1.3 Cardinal Health Nuclear Medicine Introduction
11.1.4 Cardinal Health Revenue in Nuclear Medicine Business (2020-2025)
11.1.5 Cardinal Health Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Nuclear Medicine Introduction
11.2.4 GE Healthcare Revenue in Nuclear Medicine Business (2020-2025)
11.2.5 GE Healthcare Recent Development
11.3 Jubilant Pharma
11.3.1 Jubilant Pharma Company Details
11.3.2 Jubilant Pharma Business Overview
11.3.3 Jubilant Pharma Nuclear Medicine Introduction
11.3.4 Jubilant Pharma Revenue in Nuclear Medicine Business (2020-2025)
11.3.5 Jubilant Pharma Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Nuclear Medicine Introduction
11.4.4 Novartis Revenue in Nuclear Medicine Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Curium Pharma
11.5.1 Curium Pharma Company Details
11.5.2 Curium Pharma Business Overview
11.5.3 Curium Pharma Nuclear Medicine Introduction
11.5.4 Curium Pharma Revenue in Nuclear Medicine Business (2020-2025)
11.5.5 Curium Pharma Recent Development
11.6 SIEMENS
11.6.1 SIEMENS Company Details
11.6.2 SIEMENS Business Overview
11.6.3 SIEMENS Nuclear Medicine Introduction
11.6.4 SIEMENS Revenue in Nuclear Medicine Business (2020-2025)
11.6.5 SIEMENS Recent Development
11.7 Lantheus
11.7.1 Lantheus Company Details
11.7.2 Lantheus Business Overview
11.7.3 Lantheus Nuclear Medicine Introduction
11.7.4 Lantheus Revenue in Nuclear Medicine Business (2020-2025)
11.7.5 Lantheus Recent Development
11.8 Bracco Imaging
11.8.1 Bracco Imaging Company Details
11.8.2 Bracco Imaging Business Overview
11.8.3 Bracco Imaging Nuclear Medicine Introduction
11.8.4 Bracco Imaging Revenue in Nuclear Medicine Business (2020-2025)
11.8.5 Bracco Imaging Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Nuclear Medicine Introduction
11.9.4 Bayer Revenue in Nuclear Medicine Business (2020-2025)
11.9.5 Bayer Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Nuclear Medicine Introduction
11.10.4 Eli Lilly Revenue in Nuclear Medicine Business (2020-2025)
11.10.5 Eli Lilly Recent Development
11.11 Aurobindo Pharma
11.11.1 Aurobindo Pharma Company Details
11.11.2 Aurobindo Pharma Business Overview
11.11.3 Aurobindo Pharma Nuclear Medicine Introduction
11.11.4 Aurobindo Pharma Revenue in Nuclear Medicine Business (2020-2025)
11.11.5 Aurobindo Pharma Recent Development
11.12 Mundipharma
11.12.1 Mundipharma Company Details
11.12.2 Mundipharma Business Overview
11.12.3 Mundipharma Nuclear Medicine Introduction
11.12.4 Mundipharma Revenue in Nuclear Medicine Business (2020-2025)
11.12.5 Mundipharma Recent Development
11.13 China Isotope & Radiation
11.13.1 China Isotope & Radiation Company Details
11.13.2 China Isotope & Radiation Business Overview
11.13.3 China Isotope & Radiation Nuclear Medicine Introduction
11.13.4 China Isotope & Radiation Revenue in Nuclear Medicine Business (2020-2025)
11.13.5 China Isotope & Radiation Recent Development
11.14 Yantai Dongcheng
11.14.1 Yantai Dongcheng Company Details
11.14.2 Yantai Dongcheng Business Overview
11.14.3 Yantai Dongcheng Nuclear Medicine Introduction
11.14.4 Yantai Dongcheng Revenue in Nuclear Medicine Business (2020-2025)
11.14.5 Yantai Dongcheng Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnostic Nuclear Medicine
1.2.3 Therapeutic Nuclear Medicine
1.3 Market by Application
1.3.1 Global Nuclear Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Medicine Market Perspective (2020-2031)
2.2 Global Nuclear Medicine Growth Trends by Region
2.2.1 Global Nuclear Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nuclear Medicine Historic Market Size by Region (2020-2025)
2.2.3 Nuclear Medicine Forecasted Market Size by Region (2026-2031)
2.3 Nuclear Medicine Market Dynamics
2.3.1 Nuclear Medicine Industry Trends
2.3.2 Nuclear Medicine Market Drivers
2.3.3 Nuclear Medicine Market Challenges
2.3.4 Nuclear Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Medicine Players by Revenue
3.1.1 Global Top Nuclear Medicine Players by Revenue (2020-2025)
3.1.2 Global Nuclear Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Top Nuclear Medicine Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nuclear Medicine Revenue
3.4 Global Nuclear Medicine Market Concentration Ratio
3.4.1 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Revenue in 2024
3.5 Global Key Players of Nuclear Medicine Head office and Area Served
3.6 Global Key Players of Nuclear Medicine, Product and Application
3.7 Global Key Players of Nuclear Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclear Medicine Breakdown Data by Type
4.1 Global Nuclear Medicine Historic Market Size by Type (2020-2025)
4.2 Global Nuclear Medicine Forecasted Market Size by Type (2026-2031)
5 Nuclear Medicine Breakdown Data by Application
5.1 Global Nuclear Medicine Historic Market Size by Application (2020-2025)
5.2 Global Nuclear Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nuclear Medicine Market Size (2020-2031)
6.2 North America Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nuclear Medicine Market Size by Country (2020-2025)
6.4 North America Nuclear Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nuclear Medicine Market Size (2020-2031)
7.2 Europe Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nuclear Medicine Market Size by Country (2020-2025)
7.4 Europe Nuclear Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Medicine Market Size (2020-2031)
8.2 Asia-Pacific Nuclear Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nuclear Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Nuclear Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nuclear Medicine Market Size (2020-2031)
9.2 Latin America Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nuclear Medicine Market Size by Country (2020-2025)
9.4 Latin America Nuclear Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Medicine Market Size (2020-2031)
10.2 Middle East & Africa Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nuclear Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Nuclear Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cardinal Health
11.1.1 Cardinal Health Company Details
11.1.2 Cardinal Health Business Overview
11.1.3 Cardinal Health Nuclear Medicine Introduction
11.1.4 Cardinal Health Revenue in Nuclear Medicine Business (2020-2025)
11.1.5 Cardinal Health Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Nuclear Medicine Introduction
11.2.4 GE Healthcare Revenue in Nuclear Medicine Business (2020-2025)
11.2.5 GE Healthcare Recent Development
11.3 Jubilant Pharma
11.3.1 Jubilant Pharma Company Details
11.3.2 Jubilant Pharma Business Overview
11.3.3 Jubilant Pharma Nuclear Medicine Introduction
11.3.4 Jubilant Pharma Revenue in Nuclear Medicine Business (2020-2025)
11.3.5 Jubilant Pharma Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Nuclear Medicine Introduction
11.4.4 Novartis Revenue in Nuclear Medicine Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Curium Pharma
11.5.1 Curium Pharma Company Details
11.5.2 Curium Pharma Business Overview
11.5.3 Curium Pharma Nuclear Medicine Introduction
11.5.4 Curium Pharma Revenue in Nuclear Medicine Business (2020-2025)
11.5.5 Curium Pharma Recent Development
11.6 SIEMENS
11.6.1 SIEMENS Company Details
11.6.2 SIEMENS Business Overview
11.6.3 SIEMENS Nuclear Medicine Introduction
11.6.4 SIEMENS Revenue in Nuclear Medicine Business (2020-2025)
11.6.5 SIEMENS Recent Development
11.7 Lantheus
11.7.1 Lantheus Company Details
11.7.2 Lantheus Business Overview
11.7.3 Lantheus Nuclear Medicine Introduction
11.7.4 Lantheus Revenue in Nuclear Medicine Business (2020-2025)
11.7.5 Lantheus Recent Development
11.8 Bracco Imaging
11.8.1 Bracco Imaging Company Details
11.8.2 Bracco Imaging Business Overview
11.8.3 Bracco Imaging Nuclear Medicine Introduction
11.8.4 Bracco Imaging Revenue in Nuclear Medicine Business (2020-2025)
11.8.5 Bracco Imaging Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Nuclear Medicine Introduction
11.9.4 Bayer Revenue in Nuclear Medicine Business (2020-2025)
11.9.5 Bayer Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Nuclear Medicine Introduction
11.10.4 Eli Lilly Revenue in Nuclear Medicine Business (2020-2025)
11.10.5 Eli Lilly Recent Development
11.11 Aurobindo Pharma
11.11.1 Aurobindo Pharma Company Details
11.11.2 Aurobindo Pharma Business Overview
11.11.3 Aurobindo Pharma Nuclear Medicine Introduction
11.11.4 Aurobindo Pharma Revenue in Nuclear Medicine Business (2020-2025)
11.11.5 Aurobindo Pharma Recent Development
11.12 Mundipharma
11.12.1 Mundipharma Company Details
11.12.2 Mundipharma Business Overview
11.12.3 Mundipharma Nuclear Medicine Introduction
11.12.4 Mundipharma Revenue in Nuclear Medicine Business (2020-2025)
11.12.5 Mundipharma Recent Development
11.13 China Isotope & Radiation
11.13.1 China Isotope & Radiation Company Details
11.13.2 China Isotope & Radiation Business Overview
11.13.3 China Isotope & Radiation Nuclear Medicine Introduction
11.13.4 China Isotope & Radiation Revenue in Nuclear Medicine Business (2020-2025)
11.13.5 China Isotope & Radiation Recent Development
11.14 Yantai Dongcheng
11.14.1 Yantai Dongcheng Company Details
11.14.2 Yantai Dongcheng Business Overview
11.14.3 Yantai Dongcheng Nuclear Medicine Introduction
11.14.4 Yantai Dongcheng Revenue in Nuclear Medicine Business (2020-2025)
11.14.5 Yantai Dongcheng Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Nuclear Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Diagnostic Nuclear Medicine
Table 3. Key Players of Therapeutic Nuclear Medicine
Table 4. Global Nuclear Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Nuclear Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Nuclear Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Nuclear Medicine Market Share by Region (2020-2025)
Table 8. Global Nuclear Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Nuclear Medicine Market Share by Region (2026-2031)
Table 10. Nuclear Medicine Market Trends
Table 11. Nuclear Medicine Market Drivers
Table 12. Nuclear Medicine Market Challenges
Table 13. Nuclear Medicine Market Restraints
Table 14. Global Nuclear Medicine Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Nuclear Medicine Market Share by Players (2020-2025)
Table 16. Global Top Nuclear Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2024)
Table 17. Ranking of Global Top Nuclear Medicine Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Nuclear Medicine Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Nuclear Medicine, Headquarters and Area Served
Table 20. Global Key Players of Nuclear Medicine, Product and Application
Table 21. Global Key Players of Nuclear Medicine, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Nuclear Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Nuclear Medicine Revenue Market Share by Type (2020-2025)
Table 25. Global Nuclear Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Nuclear Medicine Revenue Market Share by Type (2026-2031)
Table 27. Global Nuclear Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Nuclear Medicine Revenue Market Share by Application (2020-2025)
Table 29. Global Nuclear Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Nuclear Medicine Revenue Market Share by Application (2026-2031)
Table 31. North America Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Nuclear Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Nuclear Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Nuclear Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Nuclear Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Nuclear Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Nuclear Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Nuclear Medicine Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Nuclear Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Nuclear Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Nuclear Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Nuclear Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 46. Cardinal Health Company Details
Table 47. Cardinal Health Business Overview
Table 48. Cardinal Health Nuclear Medicine Product
Table 49. Cardinal Health Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 50. Cardinal Health Recent Development
Table 51. GE Healthcare Company Details
Table 52. GE Healthcare Business Overview
Table 53. GE Healthcare Nuclear Medicine Product
Table 54. GE Healthcare Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 55. GE Healthcare Recent Development
Table 56. Jubilant Pharma Company Details
Table 57. Jubilant Pharma Business Overview
Table 58. Jubilant Pharma Nuclear Medicine Product
Table 59. Jubilant Pharma Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 60. Jubilant Pharma Recent Development
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Nuclear Medicine Product
Table 64. Novartis Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Curium Pharma Company Details
Table 67. Curium Pharma Business Overview
Table 68. Curium Pharma Nuclear Medicine Product
Table 69. Curium Pharma Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 70. Curium Pharma Recent Development
Table 71. SIEMENS Company Details
Table 72. SIEMENS Business Overview
Table 73. SIEMENS Nuclear Medicine Product
Table 74. SIEMENS Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 75. SIEMENS Recent Development
Table 76. Lantheus Company Details
Table 77. Lantheus Business Overview
Table 78. Lantheus Nuclear Medicine Product
Table 79. Lantheus Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 80. Lantheus Recent Development
Table 81. Bracco Imaging Company Details
Table 82. Bracco Imaging Business Overview
Table 83. Bracco Imaging Nuclear Medicine Product
Table 84. Bracco Imaging Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 85. Bracco Imaging Recent Development
Table 86. Bayer Company Details
Table 87. Bayer Business Overview
Table 88. Bayer Nuclear Medicine Product
Table 89. Bayer Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 90. Bayer Recent Development
Table 91. Eli Lilly Company Details
Table 92. Eli Lilly Business Overview
Table 93. Eli Lilly Nuclear Medicine Product
Table 94. Eli Lilly Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 95. Eli Lilly Recent Development
Table 96. Aurobindo Pharma Company Details
Table 97. Aurobindo Pharma Business Overview
Table 98. Aurobindo Pharma Nuclear Medicine Product
Table 99. Aurobindo Pharma Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 100. Aurobindo Pharma Recent Development
Table 101. Mundipharma Company Details
Table 102. Mundipharma Business Overview
Table 103. Mundipharma Nuclear Medicine Product
Table 104. Mundipharma Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 105. Mundipharma Recent Development
Table 106. China Isotope & Radiation Company Details
Table 107. China Isotope & Radiation Business Overview
Table 108. China Isotope & Radiation Nuclear Medicine Product
Table 109. China Isotope & Radiation Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 110. China Isotope & Radiation Recent Development
Table 111. Yantai Dongcheng Company Details
Table 112. Yantai Dongcheng Business Overview
Table 113. Yantai Dongcheng Nuclear Medicine Product
Table 114. Yantai Dongcheng Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 115. Yantai Dongcheng Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Nuclear Medicine Picture
Figure 2. Global Nuclear Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nuclear Medicine Market Share by Type: 2024 VS 2031
Figure 4. Diagnostic Nuclear Medicine Features
Figure 5. Therapeutic Nuclear Medicine Features
Figure 6. Global Nuclear Medicine Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Nuclear Medicine Market Share by Application: 2024 VS 2031
Figure 8. Oncology Case Studies
Figure 9. Thyroid Case Studies
Figure 10. Cardiology Case Studies
Figure 11. Others Case Studies
Figure 12. Nuclear Medicine Report Years Considered
Figure 13. Global Nuclear Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Nuclear Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Nuclear Medicine Market Share by Region: 2024 VS 2031
Figure 16. Global Nuclear Medicine Market Share by Players in 2024
Figure 17. Global Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Nuclear Medicine Revenue in 2024
Figure 19. North America Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Nuclear Medicine Market Share by Country (2020-2031)
Figure 21. United States Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Nuclear Medicine Market Share by Country (2020-2031)
Figure 25. Germany Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Nuclear Medicine Market Share by Region (2020-2031)
Figure 33. China Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Nuclear Medicine Market Share by Country (2020-2031)
Figure 41. Mexico Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Nuclear Medicine Market Share by Country (2020-2031)
Figure 45. Turkey Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Cardinal Health Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 49. GE Healthcare Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 50. Jubilant Pharma Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 52. Curium Pharma Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 53. SIEMENS Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 54. Lantheus Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 55. Bracco Imaging Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 56. Bayer Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 57. Eli Lilly Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 58. Aurobindo Pharma Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 59. Mundipharma Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 60. China Isotope & Radiation Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 61. Yantai Dongcheng Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Nuclear Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Diagnostic Nuclear Medicine
Table 3. Key Players of Therapeutic Nuclear Medicine
Table 4. Global Nuclear Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Nuclear Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Nuclear Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Nuclear Medicine Market Share by Region (2020-2025)
Table 8. Global Nuclear Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Nuclear Medicine Market Share by Region (2026-2031)
Table 10. Nuclear Medicine Market Trends
Table 11. Nuclear Medicine Market Drivers
Table 12. Nuclear Medicine Market Challenges
Table 13. Nuclear Medicine Market Restraints
Table 14. Global Nuclear Medicine Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Nuclear Medicine Market Share by Players (2020-2025)
Table 16. Global Top Nuclear Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2024)
Table 17. Ranking of Global Top Nuclear Medicine Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Nuclear Medicine Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Nuclear Medicine, Headquarters and Area Served
Table 20. Global Key Players of Nuclear Medicine, Product and Application
Table 21. Global Key Players of Nuclear Medicine, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Nuclear Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Nuclear Medicine Revenue Market Share by Type (2020-2025)
Table 25. Global Nuclear Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Nuclear Medicine Revenue Market Share by Type (2026-2031)
Table 27. Global Nuclear Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Nuclear Medicine Revenue Market Share by Application (2020-2025)
Table 29. Global Nuclear Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Nuclear Medicine Revenue Market Share by Application (2026-2031)
Table 31. North America Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Nuclear Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Nuclear Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Nuclear Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Nuclear Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Nuclear Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Nuclear Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Nuclear Medicine Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Nuclear Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Nuclear Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Nuclear Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Nuclear Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 46. Cardinal Health Company Details
Table 47. Cardinal Health Business Overview
Table 48. Cardinal Health Nuclear Medicine Product
Table 49. Cardinal Health Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 50. Cardinal Health Recent Development
Table 51. GE Healthcare Company Details
Table 52. GE Healthcare Business Overview
Table 53. GE Healthcare Nuclear Medicine Product
Table 54. GE Healthcare Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 55. GE Healthcare Recent Development
Table 56. Jubilant Pharma Company Details
Table 57. Jubilant Pharma Business Overview
Table 58. Jubilant Pharma Nuclear Medicine Product
Table 59. Jubilant Pharma Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 60. Jubilant Pharma Recent Development
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Nuclear Medicine Product
Table 64. Novartis Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Curium Pharma Company Details
Table 67. Curium Pharma Business Overview
Table 68. Curium Pharma Nuclear Medicine Product
Table 69. Curium Pharma Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 70. Curium Pharma Recent Development
Table 71. SIEMENS Company Details
Table 72. SIEMENS Business Overview
Table 73. SIEMENS Nuclear Medicine Product
Table 74. SIEMENS Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 75. SIEMENS Recent Development
Table 76. Lantheus Company Details
Table 77. Lantheus Business Overview
Table 78. Lantheus Nuclear Medicine Product
Table 79. Lantheus Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 80. Lantheus Recent Development
Table 81. Bracco Imaging Company Details
Table 82. Bracco Imaging Business Overview
Table 83. Bracco Imaging Nuclear Medicine Product
Table 84. Bracco Imaging Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 85. Bracco Imaging Recent Development
Table 86. Bayer Company Details
Table 87. Bayer Business Overview
Table 88. Bayer Nuclear Medicine Product
Table 89. Bayer Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 90. Bayer Recent Development
Table 91. Eli Lilly Company Details
Table 92. Eli Lilly Business Overview
Table 93. Eli Lilly Nuclear Medicine Product
Table 94. Eli Lilly Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 95. Eli Lilly Recent Development
Table 96. Aurobindo Pharma Company Details
Table 97. Aurobindo Pharma Business Overview
Table 98. Aurobindo Pharma Nuclear Medicine Product
Table 99. Aurobindo Pharma Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 100. Aurobindo Pharma Recent Development
Table 101. Mundipharma Company Details
Table 102. Mundipharma Business Overview
Table 103. Mundipharma Nuclear Medicine Product
Table 104. Mundipharma Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 105. Mundipharma Recent Development
Table 106. China Isotope & Radiation Company Details
Table 107. China Isotope & Radiation Business Overview
Table 108. China Isotope & Radiation Nuclear Medicine Product
Table 109. China Isotope & Radiation Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 110. China Isotope & Radiation Recent Development
Table 111. Yantai Dongcheng Company Details
Table 112. Yantai Dongcheng Business Overview
Table 113. Yantai Dongcheng Nuclear Medicine Product
Table 114. Yantai Dongcheng Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 115. Yantai Dongcheng Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Nuclear Medicine Picture
Figure 2. Global Nuclear Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nuclear Medicine Market Share by Type: 2024 VS 2031
Figure 4. Diagnostic Nuclear Medicine Features
Figure 5. Therapeutic Nuclear Medicine Features
Figure 6. Global Nuclear Medicine Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Nuclear Medicine Market Share by Application: 2024 VS 2031
Figure 8. Oncology Case Studies
Figure 9. Thyroid Case Studies
Figure 10. Cardiology Case Studies
Figure 11. Others Case Studies
Figure 12. Nuclear Medicine Report Years Considered
Figure 13. Global Nuclear Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Nuclear Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Nuclear Medicine Market Share by Region: 2024 VS 2031
Figure 16. Global Nuclear Medicine Market Share by Players in 2024
Figure 17. Global Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Nuclear Medicine Revenue in 2024
Figure 19. North America Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Nuclear Medicine Market Share by Country (2020-2031)
Figure 21. United States Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Nuclear Medicine Market Share by Country (2020-2031)
Figure 25. Germany Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Nuclear Medicine Market Share by Region (2020-2031)
Figure 33. China Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Nuclear Medicine Market Share by Country (2020-2031)
Figure 41. Mexico Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Nuclear Medicine Market Share by Country (2020-2031)
Figure 45. Turkey Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Cardinal Health Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 49. GE Healthcare Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 50. Jubilant Pharma Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 52. Curium Pharma Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 53. SIEMENS Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 54. Lantheus Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 55. Bracco Imaging Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 56. Bayer Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 57. Eli Lilly Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 58. Aurobindo Pharma Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 59. Mundipharma Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 60. China Isotope & Radiation Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 61. Yantai Dongcheng Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232